VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $621,668 | +7.2% | 23,102 | +20.0% | 0.16% | +8.1% |
| Q2 2023 | $579,670 | -1.7% | 19,252 | +5.7% | 0.15% | -6.9% |
| Q1 2023 | $589,409 | -10.4% | 18,220 | -20.6% | 0.16% | -7.5% |
| Q4 2022 | $657,744 | -30.5% | 22,950 | -41.5% | 0.17% | -35.9% |
| Q3 2022 | $946,315 | +203.6% | 39,233 | +244.6% | 0.27% | +210.3% |
| Q2 2022 | $311,739 | -34.9% | 11,385 | -8.8% | 0.09% | -26.3% |
| Q1 2022 | $478,883 | -44.0% | 12,487 | -53.2% | 0.12% | -46.1% |
| Q4 2021 | $854,951 | +13.8% | 26,692 | +4.7% | 0.22% | +1.9% |
| Q3 2021 | $751,565 | +28.6% | 25,502 | +48.3% | 0.22% | +27.2% |
| Q2 2021 | $584,344 | +17.2% | 17,196 | +12.1% | 0.17% | +4.3% |
| Q1 2021 | $498,605 | +66.3% | 15,341 | +84.4% | 0.16% | +52.8% |
| Q4 2020 | $299,754 | +47.4% | 8,321 | +60.3% | 0.11% | +29.3% |
| Q3 2020 | $203,319 | – | 5,192 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |